47.73.Z - Retail sale of pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2017 | 2018 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | 0,2 | -12,4 |
EBITDA | 0,3 | 0,3 | -15,7 |
Short time liabilities | 0,4 | 0,3 | -29,7 |
Equity capital | 0,6 | 0,8 | 27,7 |
Operating profit (EBIT) | 0,3 | 0,2 | -13 |
Assets | 1 | 1,1 | 10,7 |
Net profit (loss) | 0,3 | 0,2 | -12,4 |
Cash | 0,1 | 0,2 | 127,1 |
Net income from sale | 3,2 | 3,3 | 3,5 |
Liabilities and provisions for liabilities | 0,4 | 0,3 | -15,7 |
Working assets | 1 | 1,1 | 12,7 |
Depreciation | 0 | 0 | -41,5 |
% | % | p.p. | |
Profitability of capital | 44,5 | 30,5 | -14 |
Equity capital to total assets | 60,8 | 70,2 | 9,4 |
Gross profit margin | 8,3 | 7,1 | -1,2 |
EBITDA Margin | 9,3 | 7,6 | -1,7 |
Days | Days | Days | |
Short term commitment turnover cycle | 41 | 28 | -13 |
Current financial liquidity indicator | 2.5028390884399414 | 3.3446874618530273 | 0,8 |
Net dept to EBITDA | -0.3546174168586731 | -0.9555741548538208 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane